Sodium phenylbutyrate API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

Located in:

India

Produced in:

India

MOQ: 1 kg

Employees: 50

Supply to over 40 countries around the globe

Contract manufacturing (CRAMS) services

High quality product & superior client service

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • DMF

  • CoA

Contact supplier

Replies quickly

Produced in:

China

Established in: 2011

MOQ: 100 g

Employees: 10+

Fast Response and Good Communication

Willingness To Start From Small

Flexible Payment Terms

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • CoA

  • BSE/TSE

  • MSDS

Contact supplier

Replies can take a few days

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Contact supplier

Replies slower than most

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Sodium phenylbutyrate API 1716-12-7?

Description:
Here you will find a list of producers, manufacturers and distributors of Sodium phenylbutyrate. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Sodium phenylbutyrate 
Synonyms:
 
Cas Number:
1716-12-7 
DrugBank number:
DB06819 
Unique Ingredient Identifier:
NT6K61736T

About Sodium phenylbutyrate

Why are people looking for Phenylbutyric acid? A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the γ-globin gene and affects hPPARγ activation.

Check who is selling Phenylbutyric acid in the overview above.

Sodium phenylbutyrate is a type of Means in metabolic disorders


The pharmaceutical API subcategory of means in metabolic disorders refers to a group of active pharmaceutical ingredients (APIs) that are utilized in the treatment of various metabolic disorders. Metabolic disorders are medical conditions that involve disruptions in the normal metabolic processes of the body, such as those related to glucose metabolism, lipid metabolism, or hormone regulation.

The means in metabolic disorders APIs encompass a diverse range of compounds that target specific pathways or enzymes involved in metabolic regulation. These APIs play a crucial role in managing conditions like diabetes, obesity, hyperlipidemia, and hormonal imbalances. They are often incorporated into medications designed to improve metabolic function and restore the balance of key biomolecules in the body.

Common APIs in this subcategory include biguanides, sulfonylureas, thiazolidinediones, dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and sodium-glucose co-transporter 2 (SGLT2) inhibitors. These APIs exert their effects through various mechanisms such as enhancing insulin sensitivity, increasing insulin secretion, reducing glucose production, and promoting weight loss.

The development of means in metabolic disorders APIs involves extensive research and rigorous testing to ensure their efficacy, safety, and compatibility with existing treatment regimens. Pharmaceutical companies collaborate with researchers and regulatory authorities to conduct clinical trials and obtain necessary approvals before these APIs can be integrated into commercial medications.

In summary, means in metabolic disorders APIs are a vital component of pharmaceutical interventions aimed at managing metabolic disorders. By targeting specific metabolic pathways, these APIs contribute to improving patient outcomes and enhancing their overall quality of life.


Sodium phenylbutyrate (Means in metabolic disorders), classified under Metabolic Bone Disease Agents


Metabolic Bone Disease Agents are a category of pharmaceutical active pharmaceutical ingredients (APIs) that are specifically designed to treat and manage conditions related to the bones and their metabolism. These agents play a crucial role in the treatment of various metabolic bone diseases, including osteoporosis, Paget's disease, and rickets.

The primary function of Metabolic Bone Disease Agents is to regulate bone remodeling and maintain bone health. They achieve this by targeting specific pathways involved in bone metabolism, such as osteoclast and osteoblast activity, calcium regulation, and vitamin D metabolism.

These APIs are commonly used in the development of medications, including oral tablets, injectables, and topical formulations, for the effective treatment of metabolic bone diseases. They are carefully formulated to optimize their pharmacokinetic and pharmacodynamic properties, ensuring maximum efficacy and minimal side effects.

Metabolic Bone Disease Agents encompass a range of substances, including bisphosphonates, selective estrogen receptor modulators (SERMs), calcitonin, and vitamin D analogs. These APIs act through different mechanisms to address specific aspects of bone health, such as inhibiting bone resorption, promoting bone formation, or regulating calcium levels.

In conclusion, Metabolic Bone Disease Agents are a vital category of pharmaceutical APIs used in the development of medications for the treatment and management of various metabolic bone diseases. These agents target specific pathways involved in bone metabolism to regulate bone remodeling, enhance bone health, and alleviate the symptoms associated with these conditions.



Sodium phenylbutyrate manufacturers | traders | suppliers

We have 3 companies offering Sodium phenylbutyrate produced in 2 different countries.

Get in contact with the supplier of your choice:

  • Hari Ganesh Pharma Private Limited from India, product country of origin India
  • Shandong Octagon Chemicals Limited from China, product country of origin China
  • Alchymars ICM SM from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.